(2R)-N-[(6S,8S,14S)-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]-3-methyl-2-[(1-prop-2-enoylazetidin-3-yl)oxymethyl]butanamide

C47H62F3N7O8 — CID 170075359

IUPAC(2R)-N-[(6S,8S,14S)-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]-3-methyl-2-[(1-prop-2-enoylazetidin-3-yl)oxymethyl]butanamide
SMILESC=CC(=O)N1CC(OC[C@H](C(=O)N[C@H]2C[C@H]3CN(CCO3)c3ccc4c(c3)c(c(-c3cccnc3[C@H](C)OC)n4CC(F)(F)F)CC(C)(C)COC(=O)[C@@H]3CCCN(N3)C2=O)C(C)C)C1
InChIInChI=1S/C47H62F3N7O8/c1-8-40(58)55-23-32(24-55)64-25-36(28(2)3)43(59)52-38-20-31-22-54(17-18-63-31)30-13-14-39-34(19-30)35(21-46(5,6)27-65-45(61)37-12-10-16-57(53-37)44(38)60)42(56(39)26-47(48,49)50)33-11-9-15-51-41(33)29(4)62-7/h8-9,11,13-15,19,28-29,31-32,36-38,53H,1,10,12,16-18,20-27H2,2-7H3,(H,52,59)/t29-,31-,36-,37-,38-/m0/s1
InChIKeyOJVWBNLISQJUOU-DFTKCVGKSA-N
MW910.05 g/mol
LogP5.36
Rot. Bonds11

About (2R)-N-[(6S,8S,14S)-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]-3-methyl-2-[(1-prop-2-enoylazetidin-3-yl)oxymethyl]butanamide

(2R)-N-[(6S,8S,14S)-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]-3-methyl-2-[(1-prop-2-enoylazetidin-3-yl)oxymethyl]butanamide (PubChem CID 170075359) has the molecular formula C47H62F3N7O8 and a molecular weight of 910.05 g/mol. Its IUPAC name is (2R)-N-[(6S,8S,14S)-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]-3-methyl-2-[(1-prop-2-enoylazetidin-3-yl)oxymethyl]butanamide.

Molecular Properties

Compound Name(2R)-N-[(6S,8S,14S)-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]-3-methyl-2-[(1-prop-2-enoylazetidin-3-yl)oxymethyl]butanamide
PubChem CID170075359
Molecular FormulaC47H62F3N7O8
Molecular Weight910.05 g/mol
Exact Mass909.46
IUPAC Name(2R)-N-[(6S,8S,14S)-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]-3-methyl-2-[(1-prop-2-enoylazetidin-3-yl)oxymethyl]butanamide
SMILESC=CC(=O)N1CC(OC[C@H](C(=O)N[C@H]2C[C@H]3CN(CCO3)c3ccc4c(c3)c(c(-c3cccnc3[C@H](C)OC)n4CC(F)(F)F)CC(C)(C)COC(=O)[C@@H]3CCCN(N3)C2=O)C(C)C)C1
InChIInChI=1S/C47H62F3N7O8/c1-8-40(58)55-23-32(24-55)64-25-36(28(2)3)43(59)52-38-20-31-22-54(17-18-63-31)30-13-14-39-34(19-30)35(21-46(5,6)27-65-45(61)37-12-10-16-57(53-37)44(38)60)42(56(39)26-47(48,49)50)33-11-9-15-51-41(33)29(4)62-7/h8-9,11,13-15,19,28-29,31-32,36-38,53H,1,10,12,16-18,20-27H2,2-7H3,(H,52,59)/t29-,31-,36-,37-,38-/m0/s1
InChIKeyOJVWBNLISQJUOU-DFTKCVGKSA-N
XLogP5.36
TPSA156.80 Ų
H-Bond Donors2
H-Bond Acceptors12
Rotatable Bonds11
Heavy Atoms65
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500910.05
LogP ≤ 55.36
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze (2R)-N-[(6S,8S,14S)-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]-3-methyl-2-[(1-prop-2-enoylazetidin-3-yl)oxymethyl]butanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R)-N-[(6S,8S,14S)-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]-3-methyl-2-[(1-prop-2-enoylazetidin-3-yl)oxymethyl]butanamide?
The IUPAC name of (2R)-N-[(6S,8S,14S)-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]-3-methyl-2-[(1-prop-2-enoylazetidin-3-yl)oxymethyl]butanamide (CID 170075359) is (2R)-N-[(6S,8S,14S)-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]-3-methyl-2-[(1-prop-2-enoylazetidin-3-yl)oxymethyl]butanamide.
What is the SMILES notation for (2R)-N-[(6S,8S,14S)-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]-3-methyl-2-[(1-prop-2-enoylazetidin-3-yl)oxymethyl]butanamide?
The canonical SMILES for (2R)-N-[(6S,8S,14S)-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]-3-methyl-2-[(1-prop-2-enoylazetidin-3-yl)oxymethyl]butanamide is C=CC(=O)N1CC(OC[C@H](C(=O)N[C@H]2C[C@H]3CN(CCO3)c3ccc4c(c3)c(c(-c3cccnc3[C@H](C)OC)n4CC(F)(F)F)CC(C)(C)COC(=O)[C@@H]3CCCN(N3)C2=O)C(C)C)C1.
What is the InChIKey of (2R)-N-[(6S,8S,14S)-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]-3-methyl-2-[(1-prop-2-enoylazetidin-3-yl)oxymethyl]butanamide?
The InChIKey is OJVWBNLISQJUOU-DFTKCVGKSA-N. The full InChI is InChI=1S/C47H62F3N7O8/c1-8-40(58)55-23-32(24-55)64-25-36(28(2)3)43(59)52-38-20-31-22-54(17-18-63-31)30-13-14-39-34(19-30)35(21-46(5,6)27-65-45(61)37-12-10-16-57(53-37)44(38)60)42(56(39)26-47(48,49)50)33-11-9-15-51-41(33)29(4)62-7/h8-9,11,13-15,19,28-29,31-32,36-38,53H,1,10,12,16-18,20-27H2,2-7H3,(H,52,59)/t29-,31-,36-,37-,38-/m0/s1.
What are the key properties of (2R)-N-[(6S,8S,14S)-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]-3-methyl-2-[(1-prop-2-enoylazetidin-3-yl)oxymethyl]butanamide?
(2R)-N-[(6S,8S,14S)-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]-3-methyl-2-[(1-prop-2-enoylazetidin-3-yl)oxymethyl]butanamide has a molecular weight of 910.05 g/mol, XLogP of 5.36, 11 rotatable bonds, 2 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-N-[(6S,8S,14S)-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]-3-methyl-2-[(1-prop-2-enoylazetidin-3-yl)oxymethyl]butanamide is sourced from PubChem (CID 170075359), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).